| Clinical translation and first in-human use of [44Sc] Sc-PSMA-617 for PET imaging of metastasized castrate-resistant prostate cancer E Eppard, A de la Fuente, M Benešová, A Khawar, RA Bundschuh, ... Theranostics 7 (18), 4359, 2017 | 134 | 2017 |
| Prediction of Normal Organ Absorbed Doses for [177Lu]Lu-PSMA-617 Using [44Sc]Sc-PSMA-617 Pharmacokinetics in Patients With Metastatic Castration Resistant Prostate Carcinoma. BRA Khawar A, Eppard E, Sinnes JP, Roesch F, Ahmadzadehfar H, Kürpig S ... clinical nuclear medicine 43 (7), 486-491, 2018 | 46 | 2018 |
| Preliminary results of biodistribution and dosimetric analysis of [68Ga]Ga-DOTAZOL: a new zoledronate-based bisphosphonate for PET/CT diagnosis of bone … A Khawar, E Eppard, F Roesch, H Ahmadzadehfar, S Kürpig, ... Annals of Nuclear Medicine 33, 404-413, 2019 | 43 | 2019 |
| Biodistribution and post-therapy dosimetric analysis of [177Lu]Lu-DOTAZOL in patients with osteoblastic metastases: first results A Khawar, E Eppard, F Roesch, H Ahmadzadehfar, S Kürpig, ... EJNMMI research 9, 1-10, 2019 | 36 | 2019 |
| [44Sc] Sc-PSMA-617 biodistribution and dosimetry in patients with metastatic castration-resistant prostate carcinoma A Khawar, E Eppard, JP Sinnes, F Roesch, H Ahmadzadehfar, S Kuerpig, ... Clinical Nuclear Medicine 43 (5), 323-330, 2018 | 31 | 2018 |
| Role of Tc99m MIBI SPECT in the Assessment of Treatment Response in Pharyngeal Carcinoma A Khawar, MA Rafique, RA Jafri, S Saeed Annals of the New York Academy of Sciences 1138 (1), 50-57, 2008 | 8 | 2008 |
| Clinical translation and first in-human use of [44Sc] Sc-PSMA-617 for PET imaging of metastasized castrate-resistant prostate cancer. Theranostics. 2017; 7: 4359–69 E Eppard, A de la Fuente, M Benešová, A Khawar, RA Bundschuh, ... | 8 | |
| [177Lu] Lu-DOTA-zoledronate therapy–first application in a patient with primary osseous metastatic bronchial carcinoma B Kreppel, FC Gaertner, H Ahmadzadehfar, A Khawar, F Roesch, ... Nuklearmedizin-NuclearMedicine 59 (03), 281-283, 2020 | 6 | 2020 |
| Biodistribution and Radiation Dosimetric Analysis of [68Ga]Ga-RM2: A Potent GRPR Antagonist in Prostate Carcinoma Patients M Haendeler, A Khawar, H Ahmadzadehfar, S Kürpig, M Meisenheimer, ... Radiation 1 (1), 33-44, 2020 | 5 | 2020 |
| Comparison of gamma camera-based methods to measure glomerular filtration rate in potential kidney donors S Saeed, S Saeed, A Khawar, M Yousuf, T Bukhari, M Sohaib Nuclear Medicine Communications 36 (5), 481-485, 2015 | 3 | 2015 |
| Comparison of Maximum Permissible Activity of I-131 Determined by Benua and Leeper Method and Blood Absorbed Dose Method in Differentiated Thyroid Carcinoma Patients TA Afridi, M Waqar, A Khawar, N Marwat, ZA Soomro J. Radiat. Nucl. Appl. An Int. J., no. I–2022, 45-49, 2022 | 2 | 2022 |
| Quantitative analysis in Parathyroid scintigraphy: [99mTc]Tc-MIBI SPECT/CT a tool for noninvasive characterization of parathyroid lesions S Bashir, S Fatima, A Ammar, A Khawar Clinical and Translational Imaging 12 (1), 81-89, 2024 | 1 | 2024 |
| Biodistribution and radiation dosimetry of [68Ga] Ga-RM2 M Haendeler, A Khawar, S Kuerpig, M Meisenheimer, M Essler, ... Nuklearmedizin-NuclearMedicine 58 (02), P18, 2019 | 1 | 2019 |
| Biodistribution and dosimetry with [Sc-44] Sc-PSMA-617: preliminary results E Eppard, A Khawar, F Gaertner, M Essler, F Roesch, H Ahmadzadehfar, ... JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS 60, S527-S527, 2017 | 1 | 2017 |
| 5.3 [44Sc] Sc-PSMA-617 biodistribution and dosimetry in metastatic castration resistant prostate carcinoma patients (mCRPC) A Khawar, E Eppard, JP Sinnes, F Roesch, H Ahmadzadehfar, S Kürpig, ... Radiometalle in der nuklearmedizinischen Anwendung, 162, 2022 | | 2022 |
| Comparison of Three-versus Two-Time Points Time Activity Curve Analysis on Determination of Kidney Radiation Absorbed Doses in Neuroendocrine Patients Undergoing Lutetium-177 … B Khan, A Khawar, A Ammar, N Marwat World Journal of Nuclear Medicine 21 (01), A009, 2022 | | 2022 |
| Use of [177Lu] Lu PSMA-617 for Treatment of Carcinoma Breast: Tumor Lesion Dosimetric Analysis in a Single Patient A Khawar, H Ahmadzadehfar, S Kürpig, FC Gaertner, M Essler, ... World Journal of Nuclear Medicine 21 (01), A033, 2022 | | 2022 |
| New Theranostic Radionuclides for Metastatic Bone Disease A Khawar Universitäts-und Landesbibliothek Bonn, 2019 | | 2019 |
| Post Therapy Biodistribution and Dosimetric Analysis of Lutetium Zoledronate [177Lu]Lu-DOTAZOL in Patients with Osteoblastic Metastases : First Results A Khawar, E Eppard, H Ahmadzadehfar, S Kürpig, M Meisenheimer, ... EANM'18, 2018 | | 2018 |
| Preliminay Results of Biodistribution and Dosimetric Analysis with [Ga-68] Ga-DOTA (ZOL): A new bone seeking PET radionuclide A Khawar, E Eppard, H Ahmadzadehfar, S Kuerpig, M Meisenheimer, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 44, S358-S358, 2017 | | 2017 |
